Innate Immunity and Non-Hodgkin's Lymphoma (NHL) Related Genes in a Nested Case-control Study for Gastric Cancer Risk

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Oct 3

PMID 23028900

Citations 10

Authors

Sue K Park

Jae Jeong Yang

Sohee Oh

Lisa Y Cho

Seung Hyun Ma

Aesun Shin

Kwang-Pil Ko

Taesung Park

Keun-Young Yoo

Daehee Kang

Affiliations

Soon will be listed here.

Abstract

Objective: Genetic variants regulating the host immune system may contribute to the susceptibility for the development of gastric cancer. Little is known about the role of the innate immunity- and non-Hodgkin's lymphoma (NHL)-related genes for gastric cancer risk. This nested case-control study was conducted to identify candidate genes for gastric cancer risk for future studies.

Methods: In the Discovery phase, 3,072 SNPs in 203 innate immunity- and 264 NHL-related genes using the Illumine GoldenGateTM OPA Panel were analyzed in 42 matched case-control sets selected from the Korean Multi-center Cancer Cohort (KMCC). Six significant SNPs in four innate immunity (DEFA6, DEFB1, JAK3, and ACAA1) and 11 SNPs in nine NHL-related genes (INSL3, CHMP7, BCL2L11, TNFRSF8, RAD50, CASP7, CHUK, CD79B, and CLDN9) with a permutated p-value <0.01 were re-genotyped in the Replication phase among 386 cases and 348 controls. Odds ratios (ORs) for gastric cancer risk were estimated adjusting for age, smoking status, and H. pylori and CagA sero-positivity. Summarized ORs in the total study population (428 cases and 390 controls) are presented using pooled- and meta-analyses.

Results: Four SNPS had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively). INSL3 rs10421916 and rs11088680 had both a 0.8-fold decreased OR for gastric cancer (95% CIs = 0.7-0.97; and 0.7-0.9, respectively).

Conclusions: Our findings suggest that certain variants in the innate immunity and NHL-related genes affect the gastric cancer risk, perhaps by modulating infection-inflammation-immunity mechanisms that remain to be defined.

Citing Articles

Effects of RAD50 SNP, sodium intake, and H. pylori infection on gastric cancer survival in Korea.

Kwak J, Eun C, Han D, Kim H Gastric Cancer. 2023; 27(2):210-220.

PMID: 38070008 DOI: 10.1007/s10120-023-01441-x.

Incidence trends and disparities in related malignancy among US adults, 2000-2019.

Lai Y, Shi H, Wang Z, Feng Y, Bao Y, Li Y Front Public Health. 2022; 10:1056157.

PMID: 36518580 PMC: 9743990. DOI: 10.3389/fpubh.2022.1056157.

A novel pyroptosis-related gene signature for predicting laryngeal carcinoma prognosis.

Zhang H, Wang L, Yin Z, Ji L, Guo Y Int J Clin Exp Pathol. 2022; 15(8):301-315.

PMID: 36106070 PMC: 9441861.

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature.

Lu L, Zhang P, Cao X, Guan M J Oncol. 2022; 2022:1539659.

PMID: 35432539 PMC: 9007648. DOI: 10.1155/2022/1539659.

Functional genetic variants in complement component 7 confer susceptibility to gastric cancer.

Wang S, Hu W, Xie Y, Wu H, Jia Z, Zhang Z PeerJ. 2022; 10:e12816.

PMID: 35111412 PMC: 8781313. DOI: 10.7717/peerj.12816.

References

Kim N, Choi Y, Baek M, Kim Y, Kang H, Kim N . Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res. 2001; 61(1):36-8. View

Fellermann K, Stange E . Defensins -- innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol. 2001; 13(7):771-6. DOI: 10.1097/00042737-200107000-00003. View

Portal-Celhay C, Perez-Perez G . Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond). 2006; 110(3):305-14. DOI: 10.1042/CS20050232. View

Xu H, Chaturvedi R, Cheng Y, Bussiere F, Asim M, Yao M . Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res. 2004; 64(23):8521-5. DOI: 10.1158/0008-5472.CAN-04-3511. View

Yoo K, Shin H, Chang S, Lee K, Park S, Kang D . Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev. 2003; 3(1):85-92. View

Gwack J, Shin A, Kim C, Ko K, Kim Y, Jun J . CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer. 2006; 95(5):639-41. PMC: 2360680. DOI: 10.1038/sj.bjc.6603309. View

Hellmig S, Fischbach W, Goebeler-Kolve M, Folsch U, Hampe J, Schreiber S . Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2005; 46(6):869-72. DOI: 10.1080/1042819050086451. View

Micheau O, Tschopp J . Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003; 114(2):181-90. DOI: 10.1016/s0092-8674(03)00521-x. View

Campopiano D, Clarke D, Polfer N, Barran P, Langley R, Govan J . Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity. J Biol Chem. 2004; 279(47):48671-9. DOI: 10.1074/jbc.M404690200. View

10.

Ture-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, Petraki K . Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res. 2009; 28(6A):3697-700. View

11.

Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y . H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology. 2000; 119(1):97-108. DOI: 10.1053/gast.2000.8540. View

12.

Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann W, Jubner M . The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J. 2006; 20(10):1701-2. DOI: 10.1096/fj.05-4970fje. View

13.

Park C, Cho Y, Kodama T, El-Zimaity H, Osato M, Graham D . New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol. 2002; 40(12):4753-6. PMC: 154627. DOI: 10.1128/JCM.40.12.4753-4756.2002. View

14.

Lin C, Yeakley J, McDaniel T, Shen R . Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol. 2008; 496:129-42. DOI: 10.1007/978-1-59745-553-4_10. View

15.

Ng M, Hof R, Crockett J, Hope M, Berry S, Thomson J . Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun. 2009; 78(3):1345-52. PMC: 2825916. DOI: 10.1128/IAI.01226-09. View

16.

STEMMERMANN G, Mesiona W, GREENWOOD F, Bryant-Greenwood G . Immunocytochemical identification of a relaxin-like protein in gastrointestinal epithelium and carcinoma: a preliminary report. J Endocrinol. 1994; 140(2):321-5. DOI: 10.1677/joe.0.1400321. View

17.

Lunet N, Barros H . Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003; 106(6):953-60. DOI: 10.1002/ijc.11306. View

18.

Smith L, Berrieman H, OKane S, Campbell A, Maraveyas A, Cawkwell L . Immunohistochemical detection of apoptotic markers in gastric cancer. Oncol Res. 2006; 15(9):441-4. DOI: 10.3727/096504005776568246. View

19.

Katoh M, Katoh M . CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med. 2003; 11(6):683-9. View

20.

Yoo N, Lee J, Kim Y, Soung Y, Kim S, Nam S . Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS. 2004; 112(6):330-5. DOI: 10.1111/j.1600-0463.2004.apm1120602.x. View